Andrew S.  Davis net worth and biography

Andrew Davis Biography and Net Worth

Insider of Silk Road Medical
Andrew Davis joined Silk Road Medical in May of 2015 and is the Chief Commercial Officer. Andrew brings to Silk Road Medical over 20 years of experience in the medical device field with deep expertise in launching innovative, minimally invasive therapies that increase patient access and solve unmet clinical needs in cardiovascular diseases. Prior to joining Silk Road Medical, Andrew was the Vice President of Sales and Marketing at Acelity’s Advanced Wound Therapy Group. Prior to Acelity, he spent 15yrs at Medtronic and held Vice President of Sales positions for Structural Heart CoreValve, Endovascular AAA/TAA, Peripheral and Spinal/Biologics divisions. Andrew began his career in pharmaceutical sales at Johnson and Johnson after receiving a B.S. in Political Science from Florida State University.

What is Andrew S. Davis' net worth?

The estimated net worth of Andrew S. Davis is at least $7.96 million as of July 3rd, 2024. Mr. Davis owns 289,707 shares of Silk Road Medical stock worth more than $7,964,045 as of December 21st. This net worth estimate does not reflect any other assets that Mr. Davis may own. Additionally, Mr. Davis receives an annual salary of $836,330.00 as Insider at Silk Road Medical. Learn More about Andrew S. Davis' net worth.

How old is Andrew S. Davis?

Mr. Davis is currently 55 years old. There are 4 older executives and no younger executives at Silk Road Medical. The oldest executive at Silk Road Medical is Mr. Kevin M. Klemz, EVP, Chief Legal Officer & Secretary, who is 63 years old. Learn More on Andrew S. Davis' age.

What is Andrew S. Davis' salary?

As the Insider of Silk Road Medical, Inc, Mr. Davis earns $836,330.00 per year. The highest earning executive at Silk Road Medical is Mr. Lucas W. Buchanan, CFO & COO, who commands a salary of $870,550.00 per year. Learn More on Andrew S. Davis' salary.

How do I contact Andrew S. Davis?

The corporate mailing address for Mr. Davis and other Silk Road Medical executives is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. Silk Road Medical can also be reached via phone at (408) 720-9002 and via email at [email protected]. Learn More on Andrew S. Davis' contact information.

Has Andrew S. Davis been buying or selling shares of Silk Road Medical?

Andrew S. Davis has not been actively trading shares of Silk Road Medical within the last three months. Most recently, Andrew S. Davis sold 66 shares of the business's stock in a transaction on Wednesday, July 3rd. The shares were sold at an average price of $27.00, for a transaction totalling $1,782.00. Following the completion of the sale, the insider now directly owns 289,707 shares of the company's stock, valued at $7,822,089. Learn More on Andrew S. Davis' trading history.

Who are Silk Road Medical's active insiders?

Silk Road Medical's insider roster includes Lucas Buchanan (CFO), Andrew Davis (Insider), Jack Lasersohn (Director), Erica Rogers (CEO), and Richard Ruedy (EVP). Learn More on Silk Road Medical's active insiders.

Are insiders buying or selling shares of Silk Road Medical?

In the last twelve months, Silk Road Medical insiders bought shares 1 times. They purchased a total of 11,700 shares worth more than $198,783.00. In the last twelve months, insiders at the sold shares 6 times. They sold a total of 22,791 shares worth more than $414,491.49. The most recent insider tranaction occured on August, 19th when EVP Kevin M Klemz sold 2,268 shares worth more than $61,462.80. Insiders at Silk Road Medical own 3.9% of the company. Learn More about insider trades at Silk Road Medical.

Information on this page was last updated on 8/19/2024.

Andrew S. Davis Insider Trading History at Silk Road Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/3/2024Sell66$27.00$1,782.00289,707View SEC Filing Icon  
3/5/2024Sell5,481$17.17$94,108.77287,773View SEC Filing Icon  
8/3/2023Sell6,587$22.13$145,770.31109,534View SEC Filing Icon  
7/6/2023Sell69$30.79$2,124.51115,614View SEC Filing Icon  
5/1/2023Sell6,753$44.51$300,576.03115,683View SEC Filing Icon  
4/3/2023Sell6,753$39.42$266,203.26115,683View SEC Filing Icon  
3/6/2023Sell3,868$47.74$184,658.32115,683View SEC Filing Icon  
3/1/2023Sell6,753$48.02$324,279.0698,205View SEC Filing Icon  
2/1/2023Sell6,753$54.05$364,999.6598,205View SEC Filing Icon  
1/3/2023Sell6,753$52.87$357,031.1198,205View SEC Filing Icon  
12/1/2022Sell6,753$53.00$357,909.0098,205View SEC Filing Icon  
11/1/2022Sell6,753$44.17$298,280.0198,205View SEC Filing Icon  
10/3/2022Sell6,753$44.76$302,264.2898,205View SEC Filing Icon  
11/1/2021Sell4,805$60.96$292,912.80View SEC Filing Icon  
10/1/2021Sell6,324$53.90$340,863.60View SEC Filing Icon  
9/1/2021Sell6,481$59.71$386,980.5171,188View SEC Filing Icon  
8/2/2021Sell6,324$50.75$320,943.0037,115View SEC Filing Icon  
7/1/2021Sell6,324$48.06$303,931.4437,984View SEC Filing Icon  
6/1/2021Sell6,324$47.23$298,682.5232,897View SEC Filing Icon  
5/3/2021Sell6,324$62.05$392,404.2037,564View SEC Filing Icon  
4/5/2021Sell660$51.16$33,765.6031,240View SEC Filing Icon  
4/1/2021Sell6,324$50.86$321,638.6438,224View SEC Filing Icon  
3/1/2021Sell7,472$56.49$422,093.2827,274View SEC Filing Icon  
2/1/2021Sell7,472$54.12$404,384.6427,274View SEC Filing Icon  
1/4/2021Sell7,472$59.67$445,854.2427,274View SEC Filing Icon  
12/1/2020Sell7,472$56.63$423,139.3627,274View SEC Filing Icon  
11/2/2020Sell6,640$61.37$407,496.8026,442View SEC Filing Icon  
10/1/2020Sell6,635$65.60$435,256.0026,437View SEC Filing Icon  
9/1/2020Sell6,635$59.72$396,242.2026,437View SEC Filing Icon  
8/3/2020Sell6,635$47.79$317,086.6525,537View SEC Filing Icon  
7/1/2020Sell6,635$41.95$278,338.2525,537View SEC Filing Icon  
6/1/2020Sell6,635$38.67$256,575.4524,850View SEC Filing Icon  
5/1/2020Sell13,270$41.03$544,468.1031,485View SEC Filing Icon  
3/2/2020Sell6,635$40.33$267,589.5520,175View SEC Filing Icon  
1/2/2020Sell6,635$39.94$265,001.9020,175View SEC Filing Icon  
12/2/2019Sell6,635$35.70$236,869.5020,175View SEC Filing Icon  
11/20/2019Sell6,635$35.99$238,793.6518,925View SEC Filing Icon  
See Full Table

Andrew S. Davis Buying and Selling Activity at Silk Road Medical

This chart shows Andrew S Davis's buying and selling at Silk Road Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Silk Road Medical Company Overview

Silk Road Medical logo
Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.
Read More

Today's Range

Now: $27.49
Low: $27.49
High: $27.49

50 Day Range

MA: $27.31
Low: $27.01
High: $27.50

2 Week Range

Now: $27.49
Low: $6.08
High: $27.51

Volume

N/A

Average Volume

1,200,763 shs

Market Capitalization

$1.12 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.53